Tag: irritable bowel syndrome

July 16, 2018

Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C

Ironwood Pharmaceuticals (NASDAQ:IRWD) has announced the initiation of a Phase IIIb clinical trial evaluating the efficacy and safety of linaclotide...
March 19, 2018

Knight Announces Exclusive License Agreement with Ardelyx for Tenapanor

Knight Therapeutics (TSX:GUD) announced today a license agreement with Ardelyx (NASDAQ:ARDX) that provides Knight with exclusive rights to commercialize tenapanor...
February 20, 2018

5 Pharmaceutical NASDAQ Micro-Cap Stocks

Many companies are taking advantage of partnerships and M&As, whereas others are looking to maximize their own sales by solely...
January 10, 2018

Biotech Showcase Conference: Notes from the Floor, Day Two

Miss the Biotech Showcase Conference in San Fransisco? Don't worry, the Investing News Network was there on the floor of...
December 13, 2017

Lexaria Bioscience Receives U.S. Patent Award for its DehydraTECH(tm) Delivery of THC, NSAIDs, Nicotine and Vitamins

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces the United States...
August 30, 2017

Biomerica Announces Fiscal Year End 2017 Financial Results

Biomerica released their financial results for their fiscal 2017 year.
June 21, 2017

AXIM Biotech Secures Funding for Trials and Studies

AXIM Biotechnologies secured funding to continue its trials and cannabinoid research.